Is there a genetic variation association in the IL-10 and TNF α promoter gene with gestational diabetes mellitus?

Hereditas

Volumn 147, Issue 2, 2010, Pages 94-102

  Montazeri, Shabnam ^a   Nalliah, Sivalingam ^a   Radhakrishnan, Ammu Kutty ^a  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; GENETIC VARIATION; HUMANS; INTERLEUKIN-10; MIDDLE AGED; PREGNANCY; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953793728     PISSN: 00180661     EISSN: 16015223     Source Type: Journal    
DOI: 10.1111/j.1601-5223.2009.02134.x     Document Type: Article

References (44)

1. Casano-Sancho P, Lopez-Bermejot A, Frenandez-Real J M. The tumour necrosis factor (TNF) -α -308GA promoter polymorohism is related to prenatal growth and postnatal insulin resistance. Clin. Endocrinol. 2006, 64:129-135.
2. Chang YH, Huang CN, Wu CY. Association of Interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus. Human Immunol. 2005, 66:1258-1263.
3. Choy E H S, Panayi G S. Mechanisms of disease: cytokine pathways and joint inflamation in rheumatoid arthritis. N. Eng. J. Med. 2001, 344:907-916.
4. Dalziel B, Gosby A K, Richman R M. Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity. Obes. Res. 2002, 10:401-407.
5. Dandona P, Weinstock R, Thusu K. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J. Clin. Endocrinol. Metab. 1998, 83:2907-2910.
6. Edwards-Smith C J, Jonsson J R, Purdie D M. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999, 30:526-530.
7. Eskdale J, Kube D, Tesch H. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997, 46:120-128.
8. Esposito K, Pontillo A, Giugliano F. Association of low Interleukin-10 levels with the metabolic syndrome in obese women. Clinic Endocrinol. Metab. 2003, 88:1055-1058.
9. Fernandez-Real J M, Gutierrez C, Ricart W. The TNFalpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997, 46:1468-1472.
10. Grondal G, Kritjansdottir H, Gunnlaugsdottir B. Increased number of Interleukin-10 production cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families. Arthritis Rheum. 1999, 42:1649-1654.
11. Havel P J. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr. Opin. Lipidol. 2002, 13:51-59.
12. Hee C S, Gun S C, Naidu R. Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Mod. Rheumatol. 2007, 17:429-435.
13. Holmea V A, Wallace J M W, Gilmore W S. Plasma levels of the immunomodulatory cytokine interleukin-10 during normal human pregnancy: alongitudinal study. Cytokine 2003, 21:265-269.
14. Hotamisligil G S, Shargill N S, Spiegelman B M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
15. Howard M, O'Garra A, Ishida H. Biological properties of Interleukin 10. J. Clinic. Immunol. 1992, 13:198-200.
16. Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukin 10 and 1 in infectious and autoimmune diseases. Ann. Med. 1998, 30:460-473.
17. Karhukorpi J, Laitinen T, Karttunen R. The functionally important IL-10 promoter polymorphism (-1082G→A) is not a major genetic regulator in recurrent spontaneous abortions. Mol. Human Reprod. 2001, 7:201-203.
18. Kirwan JP, Hauguel-De Mouzon S, Lepercq J. TNF-α is apredictor of insulin resistance inhuman pregnancy. Diabetes 2002, 51:2207-2213.
19. Koch M, Rett K, Volk A. The tumor necrosis factor alpha -238 G A and -308 G A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of type 2 diabetic patients. Diabetologia 2000, 43:181-184.
20. Kubaszek A, Pihlajamaki J, Komarovski V. Promoter polymorphisms of the TNF-α (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. Diabetes 2003, 52:1872-1876.
21. Lee S C, Yong B P, Thomas G N. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism 2000, 49:1021-1024.
22. Lim S, Crawley E, Woo P. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 1998, 352:113.
23. Luesley D M, Baker P N. Obstetrics and gynecology, evidence based text for MRCOG 2004, Arnold Publication
24. Marzi M, Vigano A, Trabattoni D. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 1996, 106:127-133.
25. Mclachlan K A, O'Neal D, Jenkins A. Do Adiponectin, TNF-α, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab. Res. Rev. 2006, 22:131-138.
26. Metzger B E. Summary and recommendation of the third International work shop: Conference on Gestational Diabetes Mellitus. Diabetes 1991, 40:197-201.
27. Padyukov L, Hytonen A K, Smolnikova M. Polymorphism in promoter region of IL10 gene is associated with RA in women. J. Rheumatol. 2004, 31:422-425.
28. Peng X M, Huang Y S, Ma H H. IL-10 promoter polymorphisms are associated with the mode and sequel of HBe Ag seroconversion in patients with chronic hepatitis B virus infection. Live Intr. 2006, 26:326-333.
29. Raghupathy R, Makhseed M, Azizieh F. Maternal Thl- and Th2-type reactivity to placental antigens in normal and unexplained recurrent spontaneous abortions. Cell Immunol. 1999, 196:122-130.
30. Rusmusse S K, Urhammer S A, Jensen J N. The -238 and -308 G A polymorphism of the tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. J. Clin. Endocrinol. Metab. 2000, 85:1731-1734.
31. Scarpelli D, Cardellini M, Andreozzi F. Variants of the Interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects. Diabetes 2006, 55:1529-1533.
32. Shaat N, Groop L. Genetics of gestational diabetes mellitus. Curr. Med. Chem. 2007, 14:569-583.
33. Shiau M Y, Wu C Y, Huang C N. TNF α polymorphisms and type 2 diabetes mellitus in Taiwanese patients. Tissue Antigens 2003, 61:393-399.
34. Smith U, Axelsen M, Carvalho E. Insulin signaling and action in fat cells: associations with insulin resistance and type 2 diabetes. Ann. N. Y. Acad. Sci. 1999, 18:119-126.
35. Stanulla M, Schrauder A, Welt K. Tumour necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell acute lymphoblastic leukaemia. BMC Blood Disorder 2001, 1:1-6.
36. Tsiotra P C, Tsigos C, Raptis S A. TNFalpha and leptin inhibit basal and glucose-stimulated insulin secretion and gene transcription in the HIT-T15 pancreatic cells. Int. J. Obes. Relat. Metab. Disord. 2001, 25:1018-1026.
37. Turner D M, Williams D M, Sankaran D. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 1997, 24:1-8.
38. UM JY, Kim HM. Frequencies of the tumor necrosis factor gene polymorphisms in the Korean population. Hereditas 2003, 139:184-188.
39. Van Exel E, Gussekloo J, De Craen A J M. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study. Diabetes 2002, 51:1088-1092.
40. Vince G S, Johnson P M. Is there a TH2 bias in human pregnancy? J. Reprod. Immune 1996, 32:101-104.
41. Walston J, Seibert M, Yen C J. Tumor necrosis factor-alpha -238 and -308 polymorphisms are not associated with traits related to obesity and insulin resistance. Diabetes 1999, 48:2096-2098.
42. Wang S L, Liu P Q, Ding Y. Maternal serum tumor necrosis factor-alpha concentration and correlation with insulin resistance in gestational diabetes. Zhonghua Fu Chan Ke Za Zhi 2004, 39:737-740.
43. Diagnosis and classification of diabetes mellitus 1999, WHO, WHO Dept of Non-communicable Disease Surveillance Geneva
44. Winkler G, Cseh K, Baranyi E. Tumor necrosis factor system in insulin resistance in gestational diabetes. Diabetes Res. Clini. Practice 2002, 56:93-99.